According to Sangamo Therapeutics 's latest financial reports the company's current earnings are S$57.8 Million. , an increase over its 2023 earnings that were of -S$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | -S$0.14 Billion | -17.27% |
2023 | -S$0.16 Billion | -40.88% |
2022 | -S$0.27 Billion | 9.79% |
2021 | -S$0.25 Billion | 41.52% |
2020 | -S$0.18 Billion | 23.17% |
2019 | -S$0.15 Billion | 36.33% |
2018 | -S$0.11 Billion | 36.89% |
2017 | -S$75.11 Million | -22.32% |
2016 | -S$96.7 Million | 54.86% |
2015 | -S$62.45 Million | 75.62% |
2014 | -S$35.56 Million | 0.13% |
2013 | -S$35.51 Million | |
2011 | -S$47.74 Million | 43.66% |
2010 | -S$33.23 Million | 28.52% |
2009 | -S$25.86 Million | -23.55% |
2008 | -S$33.82 Million | 2.45% |
2007 | -S$33.02 Million | 19.5% |
2006 | -S$27.63 Million | 50.78% |
2005 | -S$18.33 Million | 75% |
2004 | -S$10.47 Million | -33.25% |
2003 | -S$15.69 Million | -62.27% |
2002 | -S$41.58 Million | 102.82% |
2001 | -S$20.5 Million | 23.21% |
2000 | -S$16.64 Million |